TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planned
Official procurement procedure

The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM)

Laboratory building construction work
Published value
£6,500,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: THE PIRBRIGHT INSTITUTE: "The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM)". Published status: planned. Published value: £6,500,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityTHE PIRBRIGHT INSTITUTEScope & CategoriesNot publishedSubmission Window
planned
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£6,500,000
Bidder Intelligence · Authority Profile: THE PIRBRIGHT INSTITUTE
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for THE PIRBRIGHT INSTITUTE. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
4Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityTHE PIRBRIGHT INSTITUTE
Procedure methodNot published
Procurement categoryNot published
Statusplanned
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published12 May 2023, 15:55 BST
Last source update12 May 2023, 15:55 BST
Recurring procurementNot published
ClassificationLaboratory building construction work
Delivery area
OCIDocds-h6vhtk-03c869
What is being bought
A joint initiative between the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), the Foreign, Commonwealth and Development Office (FCDO) and the Bill & Melinda Gates Foundation will see the creation of a new centre at The Pirbright Institute designed to accelerate the development of animal vaccines to combat emerging and urgent infectious diseases. The consequences of livestock disease can be catastrophic. As well as posing a very real risk to global food security and international trade, livestock disease also presents a significant threat to global human health due to its pandemic potential. While the UK remains a world-leader in the early-stage development of vaccines for both human and veterinary medicine, globally we need to strengthen our collective capacity to translate scientific discoveries into solutions for the most challenging veterinary infectious diseases. The new Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) will bridge the gaps between research and expertise in process development and manufacturing while strengthening the UK's own emergency response capacity and capability. It will bring about tangible health and economic benefits by focussing on diseases prevalent in low- and middle-income countries.
What changed
From the official release history
  1. Published value updated to £6,500,000
    12 May 2023, 15:55 BST
  2. Status changed to planned
    12 May 2023, 15:55 BST
  3. Official notice release published
    12 May 2023, 15:55 BST
  4. Buyer information updated
    12 May 2023, 15:55 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    planned
    Published valueNot published
    The successful Contractor will be responsible for designing and building a c.650m2 new-build facility for The Pirbright Institute, c.465m2 of functional space on the ground floor and c.185m2 of plant space on the first floor. The design of the facility will include biocontainment (ACDP CL2/SAPO2/GMO2), BREEAM: Very Good,. cleanrooms (up to ISO7), good manufacturing practice (GMP), net-zero carbon and equity, diversity and inclusion (EDI). The project team are currently developing the RIBA Stage 2 design in conjunction with the end-user requirements. The project team is as follows:- • Project Manager - Currie and Brown • Cost Manager - Turner and Townsend • Multi-Disciplinary Design Consultant / CMT - Scitech The purpose of this notice is to establish interest within the market that will help inform a number of strategic decisions to be adopted. It is currently considered by the project team that a D&B single-stage 'open to market' or 'framework' tender offers the quickest route to completion whilst still meeting the competition requirements set out by the Employer, based on this principle, it is anticipated that the RIBA stage 3 information would be released to the tendering contractors in November 2023 with an 8-week tender period - this is subject to contractor's interest. The Contractor would tender the works on an RIBA Stage 3 design which will form part of the contract documentation, the Contractor as part of their contractual obligations shall further develop the design making design submissions post-contract for approval by the Project Manager and the compliance monitoring team. Please note, a 'draft' stage 2 architectural design for review is available on request but is subject to the completion of the non-disclosure agreement. The contract suite proposed is NEC4, whilst this option is yet to be confirmed and may change, the expectation is that it will be Option A with 'Z Clauses' that will be included in 'draft' as part of the tender documentation. The 'desired' completion date is March 2025, but it is established we are currently running behind programme and we are trying to find ways the overrun can be mitigated, we would very much appreciate your view on a construction period using the draft stage 2 design as part of this exercise. At this point, a planning consultant has been engaged but the project is still subject to a planning submission and approval - the Contractor would be responsible for discharging residual planning conditions as required. The Contractor shall also be responsible for discharging residual BREEAM conditions (will be included within tender pack) and taking on the net-zero carbon philosophy received to completion. To consolidate our requirements, we kindly request your view on the following matters within this PIN as a minimum:- • Confirmation that you're interested in tendering for the works using a single stage tendering strategy. • Confirmation that you're interested in tendering for the works using a two-stage tendering strategy. • Your view on probable construction period using the draft architectural stage 2 information and details contained within this notice. You are not required to submit a programme, but this would be well-received. • Confirmation that you have experience and are proficient in the use of NEC3 or NEC4, specifically Option A. • Do you have experience in these type of facilities, case-study is not required but project name, cleanroom standards, size and value. More information will be requested / scored as part of the tender. • Confirmation that you'd still be interested in an 'open to market' tender, the use of a framework is subject to the PIN response i.e., if there is a singular framework that could accommodate all. • Any reservations / comments on the 'draft' architectural information or details contained within this notice. • What could we consider to make the scheme more desirable to you as a potential tendering contractor? By completing the related questionnaire see 11.2.14. Additional information. Furthermore, if you have other pertinent points then we would welcome your feedback for consideration at this early stage. Please respond to the above by email only to procurement@pirbrightinnovations.co.uk. Additional information: Draft design information and the Pirbright CVIM - F01 Prior Information Notice Questionnaire are available on request subject to the completion of a signed Non-Disclosure Agreement, which can be obtained on request from procurement@pirbrightinnovations.co.uk
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    12 May 2023, 15:55 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

THE PIRBRIGHT INSTITUTE

Contracting authority GB-COH-04394007
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published